T5	Subject 22 34	two patients
T7	Effect 49 74	acute myelocytic leukemia
T8	Treatment 86 165	exposure to cyclophosphamide, methotrexate, and 5-fluorouracil adjuvant therapy
T9	Population 22 25	two
T10	Drug 98 114	cyclophosphamide
T11	Drug 116 128	methotrexate
T12	Drug 134 148	5-fluorouracil
T6	Adverse_event 39 48	developed
T13	Combination 130 133	and
E1	Adverse_event:T6 
E2	Combination:T13 arg:T12 arg2:T10 arg3:T11